Clinical Trial Update: Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

View source ↗

Summary

A University College Cork trial is investigating mechanistic predictors of interpatient variability and Temozolomide-induced hematological toxicity in glioma pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: University College Cork | Conditions: Glioma | Status: RECRUITING